JP Morgan analyst Adrian Huerta maintains Eagle Materials (NYSE:EXP) with a Neutral and raises the price target from $130 to $140.
Acurx Pharmaceuticals, Inc. Announces $4.225M Registered Direct Offering
Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a clinical-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today